Professional Documents
Culture Documents
Drug Study Copd Final
Drug Study Copd Final
ACTION N CONSIDERATIONS
IPRATROPIUM/ALBUTE Albuterol: Beta2- This product is used Hypersensitivity to Headache, Monitor rate, depth,
ROL adrenergic to treat and prevent albuterol, ipratropium, dizziness, nausea, rhythm, type of
bronchodilator symptoms atropine and derivatives, dry mouth, shaking respiration; quality and
Brand name: Ipratropium (wheezing and soy, or peanut (tremors), rate of pulse.
Salbutamol Assess lung sounds for
Ipratropium: shortness of breath) nervousness, or
wheezing
Classification:
Anticholinergic caused by cold symptoms (bronchoconstriction) and
Clinical: Bronchodilators (parasympatholytic) ongoing lung such as stuffy nose, rales.
agent; inhibits vagally disease (chronic sneezing, cough, or Protect solution for
Dosage: mediated reflexes by obstructive sore throat. inhalation from light.
Nebulizer solution (generic) antagonizing pulmonary Store unused vials in foil
(2.5mg/0.5mg)/3mL acetylcholine action; disease-COPD whi pouch.
prevents increase in ch includes Use nebulizer mouthpiece
Onset: intracellular calcium bronchitis and instead of face mask to
5-15 minutes concentration caused by emphysema). avoid blurred vision or
interaction of aggravation of narrow-
Administration: angle glaucoma.
acetylcholine with
Nebulizer solution Can mix albuterol in
Administer via jet nebulizer muscarinic receptors on nebulizer for up to 1 hr.
connected to air compressor bronchial smooth Ensure adequate
with adequate air flow muscle hydration, control
Equip with mouthpiece or environmental
suitable air mask temperature to prevent
hyperpyrexia.
Have patient void before
taking medication to
avoid urinary retention.
Teach patient proper use
of inhaler.
Onset: Immediate